Wednesday, March 25, 2020
Cotton’s hardly the only one in Washington warning about the pharmaceutical supply chain. Marco Rubio introduced a bill in the Senate to disincentivize the use of China as a supplier for medications, a subject about which Rubio had long warned. Afterward, China threatened retaliation for the debate by cutting off those supply lines, a move which did nothing but strengthen the argument for such action.
Today, Mike Pompeo hinted that the administration might act soon to redirect supply lines back to the US, at least in part as a rebuke to Beijing that hits them squarely in their pockets. Pompeo also might have used it as a threat for China over its active “disinformation” campaign over COVID-19: